Opioidsubstitutionsbehandlung und Cannabiskonsum
Standard
Opioidsubstitutionsbehandlung und Cannabiskonsum. / Schneider, Udo; Schäfer, Ingo; Hillemacher, Thomas; Cimander, Konrad F; Wedekind, Dirk; Weirich, Steffen; Havemann-Reinecke, Ursula.
In: FORTSCHR NEUROL PSYC, Vol. 87, No. 10, 10.2019, p. 548-553.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Opioidsubstitutionsbehandlung und Cannabiskonsum
AU - Schneider, Udo
AU - Schäfer, Ingo
AU - Hillemacher, Thomas
AU - Cimander, Konrad F
AU - Wedekind, Dirk
AU - Weirich, Steffen
AU - Havemann-Reinecke, Ursula
PY - 2019/10
Y1 - 2019/10
N2 - OBJECTIVES: More than 30 % of patients participating in an opioid maintenance program consume cannabis. This article describes the effects of additional cannabis use during an opioid maintenance treatment program.METHODS: Narrative literature research using online publication databases (MedLine, PubMed) RESULTS: The additional use of cannabis during an opioid maintenance treatment program may have negative side effects.CONCLUSION: Cannabis use should be discussed with the patient. It is in principle not a reason for discontinuing an opioid maintenance treatment program.
AB - OBJECTIVES: More than 30 % of patients participating in an opioid maintenance program consume cannabis. This article describes the effects of additional cannabis use during an opioid maintenance treatment program.METHODS: Narrative literature research using online publication databases (MedLine, PubMed) RESULTS: The additional use of cannabis during an opioid maintenance treatment program may have negative side effects.CONCLUSION: Cannabis use should be discussed with the patient. It is in principle not a reason for discontinuing an opioid maintenance treatment program.
KW - Analgesics, Opioid/therapeutic use
KW - Cannabis/adverse effects
KW - Humans
KW - Marijuana Smoking/adverse effects
KW - Opioid-Related Disorders/therapy
U2 - 10.1055/a-0918-5961
DO - 10.1055/a-0918-5961
M3 - SCORING: Zeitschriftenaufsatz
C2 - 31404930
VL - 87
SP - 548
EP - 553
JO - FORTSCHR NEUROL PSYC
JF - FORTSCHR NEUROL PSYC
SN - 0720-4299
IS - 10
ER -